H1: Funding, Investors & Team (Sep 2026)
H1 provides a global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organizations. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.
H1 has raised $110M across 2 funding rounds on record, the most recent a Debt Financing of $10.0M announced in Jun 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
H1 Company Profile and Key Stats
Latest funding round on record: Jun 2022.
H1 Funding Rounds
H1 raised $100M in a Series C announced in Nov 2021.
7 months later, a Debt Financing of $10.0M was announced in Jun 2022.
H1 Founders and Leadership Team
Contact details for the H1 team: 2 of 2 have an email address on file.
Start 14-day free trial →H1 Funding Compared to Other Biotechnology Startups
H1's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like H1 in Biotechnology and New York
Companies Similar to H1
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
H1 Funding FAQs
What does H1 do?
H1 provides a global healthcare platform to help life sciences companies, hospitals, academic medical centers, and health systems connect with providers, find clinical research, locate industry experts, and benchmark their organizations. As the trusted source of information on healthcare professionals and institutions, H1 connects the entire healthcare ecosystem through real-time data and clinical findings. It was founded in 2017 and is based in New York, New York.
How much funding has H1 raised?
H1 has raised $110M across 2 rounds on record. The most recent is a Debt Financing of $10.0M announced in Jun 2022.
When did H1 last raise funding?
H1's most recent funding round on record is a Debt Financing of $10.0M, announced in Jun 2022.
Who founded H1?
FundedIQ lists Ian Sax (Founder) at H1.
Who is the CEO of H1?
Ariel Katz is listed as CEO at H1.
Where is H1 headquartered?
H1 is based in New York, United States.
How many employees does H1 have?
H1 is in the 251-500 employee band.
How does H1's funding compare to other Biotechnology startups?
H1's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's H1 Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for H1 is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.